We are live on
!
Find out more
Baird Financial Group Portfolio holdings
AUM
$64B
1-Year Est. Return
22.64%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+22.64%
3 Year Est. Return
+71.5%
5 Year Est. Return
+89.73%
10 Year Est. Return
+347.75%
AUM
$12.8B
AUM Growth
+$399M
(+3.2%)
Cap. Flow
+$42.1M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
16%
Holding
1,285
New
77
Increased
543
Reduced
535
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$50.8M |
| 2 |
Albemarle
ALB
|
+$41.4M |
| 3 |
Microchip Technology
MCHP
|
+$40.8M |
| 4 |
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
|
+$32.6M |
| 5 |
Target
TGT
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$62.9M |
| 2 |
PNRA
Panera Bread Co
PNRA
|
+$55.2M |
| 3 |
Ulta Beauty
ULTA
|
+$43.8M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$39.9M |
| 5 |
Church & Dwight Co
CHD
|
+$35.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 11.91% |
| 3 | Industrials | 11.26% |
| 4 | Financials | 9.48% |
| 5 | Consumer Discretionary | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Teva Pharmaceuticals
TEVA
$35.9B
| $7.22M | 0.06% |
217,232
-25,622
| -11% | -$793K |
|
327
WisdomTree International SmallCap Dividend Fund
DLS
$1.04B
| $7.21M | 0.06% |
103,626
+32,907
| +47% | +$2.25M |
|
|
ZAGG
328
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $7.16M | 0.06% |
827,592
-36,969
| -4% | -$295K |
|
|
PX
329
DELISTED
Praxair Inc
PX
| $7.15M | 0.06% |
53,909
-3,016
| -5% | -$387K |
|
330
Carnival Corporation Ltd
CCL
$36.1B
| $7.06M | 0.06% |
107,670
+761
| +0.7% | +$47.4K |
|
331
Roper Technologies
ROP
$36.3B
| $7.03M | 0.06% |
30,381
+1,027
| +3% | +$227K |
|
332
ConocoPhillips
COP
$147B
| $6.99M | 0.05% |
158,978
+1,163
| +0.7% | +$54.2K |
|
333
Alerian MLP ETF
AMLP
$13B
| $6.95M | 0.05% |
116,142
+9,951
| +9% | +$606K |
|
334
Becton Dickinson
BDX
$43.1B
| $6.92M | 0.05% |
36,382
+711
| +2% | +$130K |
|
335
Quanta Services
PWR
$93.9B
| $6.91M | 0.05% |
209,987
-11,269
| -5% | -$375K |
|
|
ATSG
336
DELISTED
Air Transport Services Group
ATSG
| $6.9M | 0.05% |
316,892
+6,378
| +2% | +$133K |
|
|
RDS.B
337
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $6.89M | 0.05% |
126,626
+5,734
| +5% | +$319K |
|
|
AGN
338
DELISTED
Allergan plc
AGN
| $6.87M | 0.05% |
28,278
+62
| +0.2% | +$14.6K |
|
339
Kraft Heinz
KHC
$30.4B
| $6.87M | 0.05% |
80,157
+1,447
| +2% | +$131K |
|
340
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
| $6.83M | 0.05% |
102,224
+12,390
| +14% | +$796K |
|
341
Baxter International
BAX
$11.6B
| $6.79M | 0.05% |
112,205
+3,691
| +3% | +$210K |
|
342
Clorox
CLX
$11.6B
| $6.75M | 0.05% |
50,647
+372
| +0.7% | +$50.2K |
|
343
iShares S&P 500 Value ETF
IVE
$48.9B
| $6.74M | 0.05% |
64,216
-285
| -0.4% | -$29.7K |
|
344
Truist Financial
TFC
$63.2B
| $6.71M | 0.05% |
147,735
-15,786
| -10% | -$685K |
|
345
Delta Air Lines
DAL
$55.9B
| $6.68M | 0.05% |
124,350
+26,964
| +28% | +$1.32M |
|
346
Mercury Systems
MRCY
$6.2B
| $6.6M | 0.05% |
+156,885
| New | +$6.17M |
|
347
Blackstone Mortgage Trust
BXMT
$2.82B
| $6.56M | 0.05% |
207,566
-12,609
| -6% | -$393K |
|
348
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $6.56M | 0.05% |
131,015
+38,827
| +42% | +$1.92M |
|
|
SCHW
349
Charles Schwab
SCHW
$177B
| $6.5M | 0.05% |
151,428
+23,539
| +18% | +$942K |
|
350
American Water Works
AWK
$26.3B
| $6.49M | 0.05% |
83,239
+1,339
| +2% | +$105K |
|
Similar funds
Baird Financial Group's Q2 2017 Portfolio in Review
As of Q2 2017, Baird Financial Group held 1,285 positions worth $12.8B, up 3.2% from $12.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Baird Financial Group's Q2 2017 filing shows 77 new, 543 increased, 535 reduced and 67 closed positions. Its largest new stake was Goldman Sachs ActiveBeta Emerging Markets Equity ETF: 1,055,424 shares worth $33M. The largest sale was Intuitive Surgical, an estimated $62.9M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
- Baird Financial Group's largest Q2 2017 buy was Goldman Sachs ActiveBeta Emerging Markets Equity ETF: 1,055,424 shares worth $33M.
- Baird Financial Group added most to Keurig Dr Pepper in Q2 2017, an estimated $50.8M increase.
- Baird Financial Group's biggest Q2 2017 reduction was Intuitive Surgical, cutting an estimated $62.9M.
- Baird Financial Group fully exited iShares Europe ETF in Q2 2017, selling an estimated $8.55M.
- Baird Financial Group's ten largest holdings make up 16% of its $12.8B portfolio in Q2 2017.
- Baird Financial Group opened 77 new positions and closed 67 in Q2 2017.
- Baird Financial Group's portfolio value rose 3.2% quarter-over-quarter to $12.8B.
Based on Baird Financial Group's 13F filing for Q2 2017, filed 14 Aug 2017.